Last 47 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 16.70 | 4.75 | 5.89 | 11.77 | 13.15 | 14.01 | 7.87 | 9.51 | 8.50 | 12.60 | 1.23 | 8.21 | 17.52 | 17.69 | 11.25 | 13.26 | 11.12 | 37.54 | 16.79 | 8.92 | 4.02 |
| — | -66.1% | -25.2% | +23.9% | +54.8% | +11.2% | +540.7% | +15.7% | -51.5% | -28.8% | -89.1% | -38.0% | +57.6% | -52.9% | -33.0% | +48.7% | +176.4% | +146.6% | +16.2% | +244.8% | — | |
| P/S Ratio | 1.05 | 0.70 | 0.77 | 0.79 | 0.85 | 0.77 | 0.61 | 0.60 | 0.78 | 0.64 | 0.49 | 0.37 | 0.34 | 0.42 | 0.31 | 0.26 | 0.30 | 0.31 | 0.51 | 0.46 | 0.37 |
| — | -8.9% | +25.9% | +32.5% | +8.5% | +19.4% | +24.2% | +63.1% | +130.9% | +53.0% | +57.0% | +40.7% | +15.0% | +36.1% | -38.2% | -43.2% | -20.0% | -16.1% | +72.7% | +110.3% | +160.8% | |
| P/B Ratio | 2.62 | 1.81 | 1.87 | 1.95 | 2.07 | 1.95 | 1.48 | 1.42 | 1.99 | 1.66 | 1.38 | 1.43 | 1.33 | 1.71 | 1.31 | 1.13 | 1.24 | 1.39 | 2.18 | 2.09 | 1.96 |
| — | -7.2% | +26.5% | +37.5% | +4.0% | +16.9% | +7.1% | -0.9% | +49.8% | -2.4% | +5.2% | +26.9% | +7.2% | +22.6% | -39.9% | -46.1% | -36.9% | -38.8% | +16.8% | +41.0% | +52.2% | |
| P/FCF | 8.80 | 9.42 | 2.83 | 11.90 | 5.78 | 5.44 | 4.98 | — | 4.79 | 5.44 | 7.87 | 3.19 | 5.26 | 4.57 | 7.36 | 9.90 | 9.45 | — | 32.98 | 41.96 | 5.63 |
| — | +73.2% | -43.2% | — | +20.8% | -0.1% | -36.7% | — | -9.0% | +18.9% | +6.9% | -67.7% | -44.3% | — | -77.7% | -76.4% | +67.9% | — | +869.5% | +997.5% | +342.4% | |
| EV / EBITDA | 7.57 | 5.40 | 6.02 | 6.31 | 6.37 | 6.48 | 5.18 | 5.49 | 4.78 | 5.96 | 1.50 | 5.69 | 6.59 | 6.93 | 6.29 | 6.48 | 6.07 | 6.32 | 6.78 | 5.82 | 3.90 |
| — | -16.5% | +16.2% | +15.0% | +33.1% | +8.7% | +245.3% | -3.6% | -27.4% | -14.0% | -76.1% | -12.2% | +8.5% | +9.6% | -7.3% | +11.2% | +55.8% | +0.5% | +7.8% | +53.0% | -49.5% | |
| EV / EBIT | 9.47 | 6.54 | 5.01 | 7.83 | 7.68 | 7.87 | 5.92 | 6.49 | 5.53 | 7.31 | 1.59 | 7.25 | 9.12 | 9.45 | 8.58 | 8.99 | 8.12 | 9.98 | 9.54 | 7.40 | 4.76 |
| — | -16.9% | -15.5% | +20.8% | +39.0% | +7.8% | +272.9% | -10.6% | -39.4% | -22.7% | -81.5% | -19.3% | +12.3% | -5.3% | -10.1% | +21.4% | +70.5% | +8.9% | +3.3% | +54.8% | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 82.3% | 18.2% | 16.4% | 15.7% | 58.3% | 82.3% | 82.6% | 40.3% | 39.5% | 39.7% | 39.4% | 39.6% | 37.5% | 37.5% | 37.2% | 36.5% | 36.5% | 36.6% | 37.4% | 37.6% | 37.9% |
| — | -77.9% | -80.1% | -61.0% | +47.8% | +107.4% | +109.5% | +1.8% | +5.2% | +5.9% | +5.9% | +8.5% | +2.8% | +2.3% | -0.5% | -3.0% | -3.8% | +0.1% | +0.8% | -0.7% | +6.1% | |
| Operating Margin | 16.1% | 18.2% | 16.4% | 15.7% | 16.8% | 15.6% | 17.3% | 16.2% | 21.3% | 14.9% | 61.2% | 13.7% | 11.2% | 11.9% | 12.0% | 10.7% | 12.4% | 11.9% | 13.7% | 15.5% | 20.7% |
| — | +16.5% | -4.8% | -2.9% | -20.9% | +4.7% | -71.8% | +18.5% | +89.6% | +25.5% | +409.6% | +27.2% | -9.7% | -0.3% | -12.1% | -30.5% | -40.1% | +0.8% | +25.6% | -17.4% | +248.4% | |
| Net Margin | 6.6% | 14.7% | 13.1% | 6.7% | 6.5% | 5.5% | 7.8% | 6.3% | 9.2% | 5.1% | 40.1% | 4.5% | 2.0% | 2.4% | 2.8% | 2.0% | 2.7% | 0.8% | 3.0% | 5.1% | 9.2% |
| — | +168.6% | +68.2% | +7.1% | -29.8% | +7.7% | -80.6% | +38.2% | +362.2% | +109.7% | +1307.0% | +121.9% | -26.9% | +195.4% | -3.5% | -60.1% | -70.3% | -65.9% | +45.4% | -39.1% | +313.3% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 16.1% | 9.4% | 7.9% | 4.2% | 4.0% | 3.4% | 4.7% | 3.8% | 5.9% | 3.3% | 32.6% | 4.6% | 2.0% | 2.5% | 3.0% | 2.2% | 3.0% | 0.9% | 3.2% | 6.3% | 13.0% |
| — | +177.1% | +66.9% | +9.7% | -32.1% | +1.9% | -85.5% | -16.2% | +198.4% | +32.9% | +974.3% | +105.5% | -34.2% | +181.4% | -5.9% | -64.6% | -76.9% | -76.7% | -1.8% | -63.0% | +239.6% | |
| ROA | 4.8% | 2.7% | 2.3% | 1.3% | 1.2% | 1.0% | 1.4% | 1.1% | 1.6% | 0.9% | 7.5% | 0.9% | 0.4% | 0.5% | 0.5% | 0.4% | 0.5% | 0.1% | 0.5% | 0.9% | 1.7% |
| — | +168.5% | +65.2% | +15.1% | -26.9% | +11.6% | -81.4% | +24.9% | +336.3% | +96.3% | +1325.3% | +132.1% | -24.4% | +217.9% | +2.2% | -59.6% | -71.5% | -68.2% | +42.8% | -40.1% | +328.9% | |
| ROIC | 13.2% | 4.0% | 3.4% | 3.4% | 3.5% | 3.3% | 3.6% | 3.5% | 4.7% | 3.2% | 13.2% | 2.9% | 2.2% | 2.4% | 2.4% | 2.2% | 2.5% | 2.3% | 2.7% | 3.4% | 4.8% |
| — | +20.6% | -4.2% | -1.4% | -25.0% | +3.1% | -72.7% | +20.8% | +111.5% | +34.1% | +453.5% | +33.0% | -9.7% | +1.9% | -13.2% | -36.7% | -48.6% | -14.5% | +13.6% | -24.5% | +241.6% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.47 | 1.52 | 1.49 | 1.47 | 1.52 | 1.59 | 1.52 | 1.54 | 1.59 | 1.64 | 1.68 | 2.72 | 2.90 | 3.01 | 3.14 | 3.27 | 3.30 | 3.67 | 3.36 | 3.68 | 3.84 |
| — | -4.0% | -1.9% | -4.8% | -4.9% | -3.0% | -9.3% | -43.4% | -45.1% | -45.6% | -46.5% | -16.8% | -12.0% | -17.9% | -6.7% | -11.0% | -14.0% | -22.8% | -33.6% | -32.5% | -51.1% | |
| Debt / EBITDA | 3.06 | 10.69 | 11.89 | 11.97 | 11.91 | 12.78 | 11.90 | 12.99 | 9.92 | 13.28 | 3.69 | 15.77 | 18.99 | 18.42 | 18.39 | 20.13 | 18.75 | 19.60 | 17.45 | 16.43 | 11.56 |
| — | -16.3% | -0.1% | -7.8% | +20.1% | -3.8% | +222.7% | -17.6% | -47.8% | -27.9% | -80.0% | -21.6% | +1.3% | -6.0% | +5.4% | +22.5% | +62.2% | +3.9% | -14.8% | +20.6% | -64.3% | |
| Current Ratio | 1.76 | 1.41 | 1.36 | 1.76 | 1.71 | 1.71 | 1.78 | 1.78 | 1.58 | 1.45 | 1.44 | 1.51 | 1.43 | 1.44 | 1.39 | 1.34 | 1.40 | 1.39 | 1.31 | 1.38 | 1.28 |
| — | -17.7% | -23.6% | -1.3% | +8.3% | +18.0% | +23.1% | +18.4% | +10.2% | +0.3% | +3.8% | +12.7% | +2.3% | +4.0% | +6.0% | -3.5% | +9.3% | -5.1% | -3.4% | -6.1% | -3.9% | |
| Quick Ratio | 1.68 | 1.35 | 1.30 | 1.68 | 1.64 | 1.63 | 1.70 | 1.70 | 1.52 | 1.38 | 1.37 | 1.42 | 1.34 | 1.35 | 1.29 | 1.25 | 1.31 | 1.30 | 1.23 | 1.31 | 1.21 |
| — | -17.4% | -23.4% | -1.3% | +7.9% | +18.2% | +24.0% | +19.9% | +13.1% | +2.4% | +5.9% | +13.9% | +2.4% | +3.6% | +5.3% | -4.9% | +8.0% | -6.6% | -4.3% | -6.4% | -4.9% | |
| Interest Coverage | 4.41 | 5.02 | 6.52 | 4.32 | 4.46 | 4.12 | 4.75 | 4.23 | 5.56 | 3.89 | 15.15 | 3.29 | 2.52 | 2.65 | 2.72 | 2.47 | 2.71 | 2.19 | 2.67 | 3.39 | 4.41 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying THC stock.
Tenet Healthcare Corporation's current P/E is 16.7x. The average P/E over the last 4 quarters is 8.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Tenet Healthcare Corporation's current operating margin is 16.1%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Tenet Healthcare Corporation's business trajectory between earnings reports.